PrPC High Expression Predicts Poor Prognosis and Regulates Gastric Cancer EMT
This study demonstrates that high expression of cellular prion protein (PrPC) drives gastric cancer progression by promoting epithelial-mesenchymal transition (EMT) and correlates significantly with poor prognosis, establishing it as a valuable prognostic biomarker and potential therapeutic target.